Philip Sarajlic

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Acute Myocardial Infarction

Coronavirus Disease

Top Venues

Cardiovascular drugs and therapy

Clinical and translational medicine

European heart journal. Cardiovascular pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hildur H Arnardottir, Sven-Christian Pawelzik, Philip Sarajlic, Alessandro Quaranta, Johan Kolmert, Dorota Religa, Craig E Wheelock, Magnus Bäck
Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: A single-blind randomized controlled trial. Clinical and translational medicine 12 (9) (2022)
Philip Sarajlic, Moa Simonsson, Tomas Jernberg, Magnus Bäck, Robin Hofmann
Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study. European heart journal. Cardiovascular pharmacotherapy (2021)
Philip Sarajlic, Gonzalo Artiach, Susanna C Larsson, Magnus Bäck
Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial. Cardiovascular drugs and therapy 35 (5) (2021)